Cargando…

Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease

The study shows effects of the nonselective adenosine A(1)/A(2A) receptor antagonist caffeine and the selective A(2A) receptor antagonist KW6002 on LPS-induced changes in the extracellular levels of dopamine (DA), glutamate, adenosine, hydroxyl radical, and A(2A) receptor density in the rat striatum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gołembiowska, Krystyna, Wardas, Jadwiga, Noworyta-Sokołowska, Karolina, Kamińska, Katarzyna, Górska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666128/ https://www.ncbi.nlm.nih.gov/pubmed/23296550 http://dx.doi.org/10.1007/s12640-012-9372-1

Ejemplares similares

Effect of Some Psychoactive Drugs Used as ‘Legal Highs’ on Brain Neurotransmitters
por: Gołembiowska, Krystyna, et al.
Publicado: (2015)

Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
por: Noworyta-Sokołowska, Karolina, et al.
Publicado: (2016)

The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats
por: Kamińska, Katarzyna, et al.
Publicado: (2018)

Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats
por: Noworyta-Sokołowska, Karolina, et al.
Publicado: (2018)

The Effect of Adenosine A(2A) Receptor Antagonists on Hydroxyl Radical, Dopamine, and Glutamate in the Striatum of Rats with Altered Function of VMAT2
por: Gołembiowska, Krystyna, et al.
Publicado: (2012)

Effect of Adenosine A(2A) Receptor Antagonists and l-DOPA on Hydroxyl Radical, Glutamate and Dopamine in the Striatum of 6-OHDA-Treated Rats
por: Gołembiowska, Krystyna, et al.
Publicado: (2011)

Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5′-Cl-5′-deoxy-ENBA, in amphetamine and MK-801 rat models
por: Ossowska, Krystyna, et al.
Publicado: (2020)

The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models
por: Kosmowska, Barbara, et al.
Publicado: (2021)

Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
por: Wojtas, Adam, et al.
Publicado: (2020)

Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo
por: Domin, Helena, et al.
Publicado: (2014)

The Role of Adenosine A1 and A2A Receptors in the Caffeine Effect on MDMA-Induced DA and 5-HT Release in the Mouse Striatum
por: Górska, A. M., et al.
Publicado: (2014)

The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT(1A) receptor signaling: mechanistic studies
por: Wierońska, Joanna M., et al.
Publicado: (2014)

Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
por: Berghauzen-Maciejewska, Klemencja, et al.
Publicado: (2015)

Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2021)

Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
por: Górska, Anna Maria, et al.
Publicado: (2017)

5-HT(7) receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin
por: Kusek, Magdalena, et al.
Publicado: (2015)

Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor
por: Kosmowska, Barbara, et al.
Publicado: (2020)

Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats
por: Doboszewska, Urszula, et al.
Publicado: (2015)

Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats
por: Herian, Monika, et al.
Publicado: (2019)

The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022)

Distinct retinoic acid receptor (RAR) isotypes control differentiation of embryonal carcinoma cells to dopaminergic or striatopallidal medium spiny neurons
por: Podleśny-Drabiniok, Anna, et al.
Publicado: (2017)

Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson’s disease: mitochondrial DNA integrity
por: Essawy, Soha S., et al.
Publicado: (2017)

T4 Phage Tail Adhesin Gp12 Counteracts LPS-Induced Inflammation In Vivo
por: Miernikiewicz, Paulina, et al.
Publicado: (2016)

Adenosine A(2A) receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease
por: Mizuno, Yoshikuni, et al.
Publicado: (2013)

Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus
por: Śmiałowska, Maria, et al.
Publicado: (2011)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo
por: Wang, Wen-Wen, et al.
Publicado: (2017)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation
por: Kiers, Dorien, et al.
Publicado: (2018)

KD-64—A new selective A(2A) adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist—Caffeine does not reduce diet-induced obesity in mice
por: Kotańska, Magdalena, et al.
Publicado: (2020)

Characterization of the trigeminovascular actions of several adenosine A(2A) receptor antagonists in an in vivo rat model of migraine
por: Haanes, Kristian A., et al.
Publicado: (2018)

DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests
por: Szopa, Aleksandra, et al.
Publicado: (2018)

Do caffeine and more selective adenosine A(2A) receptor antagonists protect against dopaminergic neurodegeneration in Parkinson’s disease?
por: Chen, Jiang-Fan, et al.
Publicado: (2020)

Trisubstituted 1,3,5-Triazines as Histamine H(4) Receptor Antagonists with Promising Activity In Vivo
por: Olejarz-Maciej, Agnieszka, et al.
Publicado: (2023)

A covalent antagonist for the human adenosine A(2A) receptor
por: Yang, Xue, et al.
Publicado: (2016)

Tumor Immunotherapy Using A(2A) Adenosine Receptor Antagonists
por: Zhang, Jinfeng, et al.
Publicado: (2020)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
por: Yang, Zijian, et al.
Publicado: (2015)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e0aph4dsh0gp5egeso9tcdq8ma